Investigator

Zehra Kurdoğlu

Assoc. Prof. · Yıldırım Beyazıt Üniversitesi Tıp Fakültesi, Department of Obstetrics and Gynecology

ZKZehra Kurdoğlu
Papers(1)
Laminin receptor 1 ex…
Collaborators(4)
Gülay BulutMertihan KurdoğluRemzi ErtenZehra Küçükaydın
Institutions(1)
Van Yznc Yl Niversite…

Papers

Laminin receptor 1 expression in premalignant and malignant squamous lesions of the cervix

Laminin receptor 1 (LAMR) may have a role in the progression of premalignant squamous epithelial lesions to cervical cancer. Therefore, we aimed to investigate the expression of laminin receptor 1 (LAMR) in normal, premalignant, and malignant tissues of the uterine cervix. Paraffin blocks of 129 specimens with the diagnoses of normal cervical tissue (n = 33), cervical intraepithelial neoplasia (CIN) 1 (n = 30), CIN 2 (n = 14), CIN 3 (n = 28), and squamous cell carcinoma (n = 24) were immunohistochemically stained with LAMR antibody and its expression percentage, pattern, and intensity in these tissues were assessed. Compared to the other groups, the nonstaining with LAMR was highest in low grade squamous intraepithelial lesion (LSIL) (p < 0.0001). LAMR expression, which was positive in less than 50% of cells with weak staining, increased significantly between normal cervical epithelium and high-grade squamous intraepithelial lesion (HSIL) or invasive carcinoma, as well as between LSIL and HSIL (p < 0.0001). Between LSIL and invasive carcinoma, a significant increment was also observed for weak staining in less than 50% of cells (p < 0.001). LAMR expression, which was positive in more than 50% of cells with strong staining, was significantly higher in normal cervical tissue compared to the other groups (p < 0.0001). Disease progression related gradual increment of LAMR expression from normal cervical epithelium or LSIL towards HSIL or cervical cancer reveals that LAMR may play an important role in the transition from premalignant to malignant state in cervical lesions.

63Works
1Papers
4Collaborators
Uterine Cervical NeoplasmsCarcinoma, Squamous CellPrecancerous Conditions

Positions

2018–

Assoc. Prof.

Yıldırım Beyazıt Üniversitesi Tıp Fakültesi · Department of Obstetrics and Gynecology

2014–

Researcher

Sa?l?k Bakanl??? Ankara E?itim ve Ara?t?rma Hastanesi · Obstetrics and Gynecology

Education

2001

Hacettepe Üniversitesi T?p Fakültesi